Blood test could speed up lung cancer treatment decisions
NCT ID NCT07649629
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a blood test called liquid biopsy can quickly find genetic changes in people with advanced lung cancer. About 70 adults will give a blood sample, and researchers will compare the results to standard tissue biopsies. The goal is to see if this approach is faster and reliable enough to use in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that a simple blood test can speed up genetic testing for lung cancer, helping doctors choose treatments faster.
- What could go wrong
- This is a small, early-stage observational study. The liquid biopsy is for research only and won't guide treatment yet. It may not match tissue biopsy results or be fast enough to change practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IFO-IRE, Istituto Nazionale Tumori Regina Elena
RECRUITINGRoma, RM, 00144, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart cancer therapy: tailoring lung cancer treatment with a simple blood test
- New drug cocktail targets tough lung cancer
- New drug duo takes on advanced lung cancer
- Could a common antioxidant boost chemo for advanced lung cancer?
- Lung cancer surgery risks under the microscope: 1,000 patients studied
- New study aims to crack the code on cancer drug resistance